참고문헌
- Eun BW, Kim NH, Choi EH, Lee HJ. Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period. J Infect 2008;56:326-31. https://doi.org/10.1016/j.jinf.2008.02.018
- Defilippi A, Silvestri M, Tacchella A, Giacchino R, Melioli G, Di Marco E, et al. Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respir Med 2008;102:1762-8. https://doi.org/10.1016/j.rmed.2008.06.022
- Kwiatkowska B, Maslinska M. Macrolide therapy in chronic inflammatory diseases. Mediators Inflamm 2012;2012:636157.
- Lucier TS, Heitzman K, Liu SK, Hu PC. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob Agents Chemother 1995;39:2770-3. https://doi.org/10.1128/AAC.39.12.2770
- Hong KB, Choi EH, Lee HJ, Lee SY, Cho EY, Choi JH, et al. Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011. Emerg Infect Dis 2013;19:1281-4. https://doi.org/10.3201/eid1908.121455
- Dumke R, von Baum H, Luck PC, Jacobs E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect 2010;16:613-6. https://doi.org/10.1111/j.1469-0691.2009.02968.x
- Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis 2010;51:189-94. https://doi.org/10.1086/653535
- Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis 2012;55:1642-9. https://doi.org/10.1093/cid/cis784
- Principi N, Esposito S. Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection. J Antimicrob Chemother 2013;68:506-11. https://doi.org/10.1093/jac/dks457
- Miyashita N, Kawai Y, Akaike H, Ouchi K, Hayashi T, Kurihara T, et al. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia. BMC Infect Dis 2012;12: 126. https://doi.org/10.1186/1471-2334-12-126
- Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother 2006;50:709-12. https://doi.org/10.1128/AAC.50.2.709-712.2006
- Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother 2009;15:380-3. https://doi.org/10.1007/s10156-009-0715-7
- Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, et al. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn Microbiol Infect Dis 2010;67: 355-8. https://doi.org/10.1016/j.diagmicrobio.2010.03.004
- McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002;346:429-37. https://doi.org/10.1056/NEJMra011994
- Yoo SJ, Kim HB, Choi SH, Lee SO, Kim SH, Hong SB, et al. Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with community-acquired pneumonia: clinical impact of mutations conferring macrolide resistance. Antimicrob Agents Chemother 2012;56: 6393-6. https://doi.org/10.1128/AAC.01421-12
- Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother 2008;52:3542-9. https://doi.org/10.1128/AAC.00582-08
- Oh CE, Choi EH, Lee HJ. Detection of genetic mutations associated with macrolide resistance of Mycoplasma pneumoniae. Korean J Pediatr 2010;53:178-83. https://doi.org/10.3345/kjp.2010.53.2.178
- Korea Centers for Disease Control and Prevention. Acute infectious agents laboratory surveillance reports [Internet]. Cheongju: Korea Centers for Disease Control and Prevention; c2012 [cited 2014 Oct 2]. Available from: http://www.cdc.go.kr.
- Chironna M, Sallustio A, Esposito S, Perulli M, Chinellato I, Di Bari C, et al. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother 2011;66:734-7. https://doi.org/10.1093/jac/dkr003
- Pereyre S, Charron A, Renaudin H, Bebear C, Bebear CM. First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J Clin Microbiol 2007;45:3534-9. https://doi.org/10.1128/JCM.01345-07
- Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother 2010;16: 78-86. https://doi.org/10.1007/s10156-009-0021-4
- Yang J, Hooper WC, Phillips DJ, Talkington DF. Cytokines in Mycoplasma pneumoniae infections. Cytokine Growth Factor Rev 2004;15:157-68. https://doi.org/10.1016/j.cytogfr.2004.01.001
- Ye Y, Li S, Yajun L, Li Y, Ren T, Liu K. Mycoplasma pneumoniae 23S rRNA gene mutations and mechanisms of macrolide resistance. Lab Med 2013;44:63-8. https://doi.org/10.1309/LMYEY7P26RHWRRUL
- Cardinale F, Chironna M, Dumke R, Binetti A, Daleno C, Sallustio A, et al. Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia. Eur Respir J 2011;37:1522-4. https://doi.org/10.1183/09031936.00172510
- Sun H, Chen Z, Yan Y, Huang L, Wang M, Ji W. Epidemiology and clinical profiles of Mycoplasma pneumoniae infection in hospitalized infants younger than one year. Respir Med 2015;109:751-7. https://doi.org/10.1016/j.rmed.2015.04.006
피인용 문헌
- Clarithromycin : Emergence of drug resistance in Mycoplasma pneumoniae pneumonia: case report vol.1662, pp.1, 2017, https://doi.org/10.1007/s40278-017-33732-z
- Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju vol.32, pp.10, 2017, https://doi.org/10.3346/jkms.2017.32.10.1642
- Diagnostic value of serum IgM enzyme-linked immunosorbent assays in polymerase chain reaction-positive Mycoplasma pneumonia in children vol.6, pp.5, 2017, https://doi.org/10.4168/aard.2018.6.5.248
- Literature review and future strategies of childhood respiratory diseases in Korea vol.6, pp.suppl1, 2018, https://doi.org/10.4168/aard.2018.6.s1.s66
- Detection of Mycoplasma pneumoniae Among Children with Pneumonia Using Bacterial Culture, Polymerase Chain Reaction, and the Enzyme-linked Immunosorbent Assay Techniques in Ahvaz, Iran vol.11, pp.2, 2017, https://doi.org/10.5812/jjm.55554
- Clinical analysis of risk factors in refractory mycoplasma pneumonia in children vol.6, pp.1, 2018, https://doi.org/10.4168/aard.2018.6.1.62
- Unraveling the Metabolic Routes of Retapamulin: Insights into Drug Development of Pleuromutilins vol.62, pp.4, 2017, https://doi.org/10.1128/aac.02388-17
- Current usage and effects of steroids in the management of childhood mycoplasma pneumonia in a secondary hospital vol.6, pp.2, 2017, https://doi.org/10.4168/aard.2018.6.2.122
- Clinical features of Mycoplasma pneumonia in comparison with viral pneumoina in children: A multicenter, cross-sectional study vol.6, pp.3, 2017, https://doi.org/10.4168/aard.2018.6.3.155
- Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children vol.33, pp.43, 2018, https://doi.org/10.3346/jkms.2018.33.e268
- Wanted: The Best Second Option to Treat Macrolide-Unresponsive Mycoplasmal Pneumonia in Children vol.33, pp.43, 2017, https://doi.org/10.3346/jkms.2018.33.e281
- Prevalence and Clinical Features of Community-Acquired Pneumonia Caused by Macrolide-Resistant Mycoplasma pneumoniae Isolated from Adults in Jeju Island vol.25, pp.4, 2017, https://doi.org/10.1089/mdr.2018.0295
- Early Corticosteroid Therapy for Mycoplasma pneumoniae Pneumonia Irrespective of Used Antibiotics in Children vol.8, pp.5, 2019, https://doi.org/10.3390/jcm8050726
- Changes in the Treatment Strategies for Helicobacter pylori Infection in Children and Adolescents in Korea vol.22, pp.5, 2017, https://doi.org/10.5223/pghn.2019.22.5.417
- Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta-analysis of randomized controlled trials vol.19, pp.None, 2017, https://doi.org/10.1186/s12890-019-0990-8
- Diversity in Genotype Distribution of Mycoplasma pneumoniae Obtained from Children and Adults vol.73, pp.1, 2017, https://doi.org/10.7883/yoken.jjid.2019.037
- Real-world treatment pattern of mycoplasma pneumonia in hospitalized children: A multicenter retrospective study vol.8, pp.2, 2017, https://doi.org/10.4168/aard.2020.8.2.66
- Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance vol.175, pp.None, 2017, https://doi.org/10.1016/j.rmed.2020.106209
- Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea vol.20, pp.None, 2020, https://doi.org/10.1186/s12879-020-4810-9
- A retrospective study of azithromycin and ceftizoxime for the management of children with Mycoplasma pneumoniae pneumonia vol.100, pp.44, 2017, https://doi.org/10.1097/md.0000000000027564
- A case of pulmonary thromboembolism and splenic infarction in mycoplasma pneumonia vol.9, pp.1, 2017, https://doi.org/10.4168/aard.2021.9.1.36
- Predictive Factors of the Responses to Treatment of Mycoplasma pneumoniae Pneumonia vol.10, pp.6, 2021, https://doi.org/10.3390/jcm10061154
- Macrolide-Resistant and Macrolide-Sensitive Mycoplasma pneumoniae Pneumonia in Children Treated Using Early Corticosteroids vol.10, pp.6, 2017, https://doi.org/10.3390/jcm10061309
- Cases of macrolide‐resistant Mycoplasma pneumoniae pneumonia‐associated pulmonary thromboembolism vol.56, pp.6, 2017, https://doi.org/10.1002/ppul.25298
- Mutations in domain V of Mycoplasma pneumoniae 23S rRNA and clinical characteristics of pediatric M. pneumoniae pneumonia in Nanjing, China vol.49, pp.6, 2021, https://doi.org/10.1177/03000605211016376
- Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA vol.27, pp.6, 2021, https://doi.org/10.3201/eid2706.203206
- Clinical Significance of Pleural Effusion in Mycoplasma pneumoniae Pneumonia in Children vol.10, pp.9, 2021, https://doi.org/10.3390/pathogens10091075
- Macrolide Resistance, Clinical Features, and Cytokine Profiles in Taiwanese Children With Mycoplasma pneumoniae Infection vol.8, pp.9, 2017, https://doi.org/10.1093/ofid/ofab416
- Long-term macrolide treatment for non-cystic fibrosis bronchiectasis in children: a meta-analysis vol.11, pp.1, 2017, https://doi.org/10.1038/s41598-021-03778-8
- Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis vol.21, pp.1, 2021, https://doi.org/10.1186/s12879-021-06508-7